1. Home
  2. HWKN vs ADPT Comparison

HWKN vs ADPT Comparison

Compare HWKN & ADPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hawkins Inc.

HWKN

Hawkins Inc.

HOLD

Current Price

$147.99

Market Cap

2.8B

ML Signal

HOLD

Logo Adaptive Biotechnologies Corporation

ADPT

Adaptive Biotechnologies Corporation

HOLD

Current Price

$14.54

Market Cap

2.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HWKN
ADPT
Founded
1938
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Specialty Chemicals
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
2.3B
IPO Year
1995
2019

Fundamental Metrics

Financial Performance
Metric
HWKN
ADPT
Price
$147.99
$14.54
Analyst Decision
Buy
Strong Buy
Analyst Count
2
9
Target Price
$200.00
$17.78
AVG Volume (30 Days)
139.2K
2.0M
Earning Date
05-13-2026
04-30-2026
Dividend Yield
0.51%
N/A
EPS Growth
12.26
63.89
EPS
3.17
N/A
Revenue
$974,431,000.00
$276,976,000.00
Revenue This Year
$12.37
$3.98
Revenue Next Year
$6.30
$22.72
P/E Ratio
$47.40
N/A
Revenue Growth
6.01
54.77
52 Week Low
$117.51
$6.77
52 Week High
$186.15
$20.76

Technical Indicators

Market Signals
Indicator
HWKN
ADPT
Relative Strength Index (RSI) 51.00 52.25
Support Level $142.77 $12.19
Resistance Level $154.95 $17.72
Average True Range (ATR) 5.01 0.99
MACD -0.15 0.14
Stochastic Oscillator 31.34 70.42

Price Performance

Historical Comparison
HWKN
ADPT

About HWKN Hawkins Inc.

Hawkins Inc manufactures and sells a variety of chemicals and ingredients. The firm organizes itself into three segments based on the product type. The industrial segment, which generates the majority of revenue, sells private label bleach, caustic soda, sulfuric acid, hydrochloric acid, phosphoric acid, potassium hydroxide, and aqua ammonia. The water treatment segment sells chemicals and equipment used to treat potable water, municipal and industrial wastewater, industrial process water, and non-residential swimming pool water. The health and nutrition segment sells ingredients to food, beverage, personal care, and dietary supplement producers. The majority of revenue is gained from Water Treatment.

About ADPT Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is a test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers. The company has two operating segments: Minimal Residual Disease and Immune Medicine. The company generates the majority of its revenue from the Minimal Residual Disease segment.

Share on Social Networks: